3-(4-bromophenyl)-4,5-diphenyl-1,2,4-triazole;4-[3-(4-bromophenyl)-5-phenyl-1,2,4-triazol-4-yl]pyridine;2-[5-(4-methylphenyl)-4-phenyl-1,2,4-triazol-3-yl]pyridine;2-[5-(4-methylphenyl)-4-pyridin-4-yl-1,2,4-triazol-3-yl]pyridine
C78H58Br2N16 — CID 157075510
Data last refreshed: (MolForge compound catalog, from PubChem)
About 3-(4-bromophenyl)-4,5-diphenyl-1,2,4-triazole;4-[3-(4-bromophenyl)-5-phenyl-1,2,4-triazol-4-yl]pyridine;2-[5-(4-methylphenyl)-4-phenyl-1,2,4-triazol-3-yl]pyridine;2-[5-(4-methylphenyl)-4-pyridin-4-yl-1,2,4-triazol-3-yl]pyridine
3-(4-bromophenyl)-4,5-diphenyl-1,2,4-triazole;4-[3-(4-bromophenyl)-5-phenyl-1,2,4-triazol-4-yl]pyridine;2-[5-(4-methylphenyl)-4-phenyl-1,2,4-triazol-3-yl]pyridine;2-[5-(4-methylphenyl)-4-pyridin-4-yl-1,2,4-triazol-3-yl]pyridine (PubChem CID 157075510) has the molecular formula C78H58Br2N16 and a molecular weight of 1379.24 g/mol. Its IUPAC name is 3-(4-bromophenyl)-4,5-diphenyl-1,2,4-triazole;4-[3-(4-bromophenyl)-5-phenyl-1,2,4-triazol-4-yl]pyridine;2-[5-(4-methylphenyl)-4-phenyl-1,2,4-triazol-3-yl]pyridine;2-[5-(4-methylphenyl)-4-pyridin-4-yl-1,2,4-triazol-3-yl]pyridine.
Molecular Properties
| Compound Name | 3-(4-bromophenyl)-4,5-diphenyl-1,2,4-triazole;4-[3-(4-bromophenyl)-5-phenyl-1,2,4-triazol-4-yl]pyridine;2-[5-(4-methylphenyl)-4-phenyl-1,2,4-triazol-3-yl]pyridine;2-[5-(4-methylphenyl)-4-pyridin-4-yl-1,2,4-triazol-3-yl]pyridine |
|---|---|
| PubChem CID | 157075510 |
| Molecular Formula | C78H58Br2N16 |
| Molecular Weight | 1379.24 g/mol |
| Exact Mass | 1376.34 |
| IUPAC Name | 3-(4-bromophenyl)-4,5-diphenyl-1,2,4-triazole;4-[3-(4-bromophenyl)-5-phenyl-1,2,4-triazol-4-yl]pyridine;2-[5-(4-methylphenyl)-4-phenyl-1,2,4-triazol-3-yl]pyridine;2-[5-(4-methylphenyl)-4-pyridin-4-yl-1,2,4-triazol-3-yl]pyridine |
| SMILES | Brc1ccc(-c2nnc(-c3ccccc3)n2-c2ccccc2)cc1.Brc1ccc(-c2nnc(-c3ccccc3)n2-c2ccncc2)cc1.Cc1ccc(-c2nnc(-c3ccccn3)n2-c2ccccc2)cc1.Cc1ccc(-c2nnc(-c3ccccn3)n2-c2ccncc2)cc1 |
| InChI | InChI=1S/C20H14BrN3.C20H16N4.C19H13BrN4.C19H15N5/c21-17-13-11-16(12-14-17)20-23-22-19(15-7-3-1-4-8-15)24(20)18-9-5-2-6-10-18;1-15-10-12-16(13-11-15)19-22-23-20(18-9-5-6-14-21-18)24(19)17-7-3-2-4-8-17;20-16-8-6-15(7-9-16)19-23-22-18(14-4-2-1-3-5-14)24(19)17-10-12-21-13-11-17;1-14-5-7-15(8-6-14)18-22-23-19(17-4-2-3-11-21-17)24(18)16-9-12-20-13-10-16/h1-14H;2-14H,1H3;1-13H;2-13H,1H3 |
| InChIKey | ACXUEZRVCPGMKI-UHFFFAOYSA-N |
| XLogP | 18.13 |
| TPSA | 174.40 Ų |
| H-Bond Donors | |
| H-Bond Acceptors | 16 |
| Rotatable Bonds | 12 |
| Heavy Atoms | 96 |
| Complexity | — |
Lipinski Rule of Five
3 violations
| Rule | Value |
|---|---|
| MW ≤ 500 | 1379.24 |
| LogP ≤ 5 | 18.13 |
| H-Bond Donors ≤ 5 | 0 |
| H-Bond Acceptors ≤ 10 | 16 |
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 157075510 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.